跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEMAZYRE TABLETS 4.5 MG - HSA Drug Approval Details
Approvals
/
HSA
/
PEMAZYRE TABLETS 4.5 MG
Approved
THERAPEUTIC
PEMAZYRE TABLETS 4.5 MG
Lonza Tampa LLC
🇸🇬 Health Sciences Authority
Approval Date
Jul 9, 2024
Approval ID
2863a47e0f01065a
Company
Lonza Tampa LLC
Type
Therapeutic
Approval Details
Approval Id
2863a47e0f01065a
Drug Name
PEMAZYRE TABLETS 4.5 MG
Product Name
PEMAZYRE TABLETS 4.5 MG
Approval Number
SIN17042P
Approval Date
2024-07-09
Registrant
SPECIALISED THERAPEUTICS ASIA PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
L01EN02
Pharma Manufacturer Name
SPECIALISED THERAPEUTICS ASIA PTE. LTD.
Company Detail Path
/organization/specialised-therapeutics-asia-pte-ltd
Active Ingredients
Pemigatinib
4.50 mg
Pemigatinib
4.50 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 9, 2024
Approval ID
2863a47e0f01065a
Type
Therapeutic
Back to HSA Approvals